Healthcare provider profile · identity verified

Maria Engstrom Pharr, MD

Family Practice · ELIZABETH CITY, NC · NPI 1972602530

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	386	86
Atorvastatin Calcium	Atorvastatin Calcium	381	101
Levothyroxine Sodium	Levothyroxine Sodium	286	70
Losartan Potassium	Losartan Potassium	230	57
Lisinopril	Lisinopril	185	51
Omeprazole	Omeprazole	183	51
Hydrochlorothiazide	Hydrochlorothiazide	171	40
Metoprolol Succinate	Metoprolol Succinate	154	37
Gabapentin	Gabapentin	140	37
Simvastatin	Simvastatin	135	26
Rosuvastatin Calcium	Rosuvastatin Calcium	120	30
Alprazolam	Alprazolam	96	16
Pantoprazole Sodium	Pantoprazole Sodium	96	26
Furosemide	Furosemide	90	32
Lorazepam	Lorazepam	82	21
Fluticasone Propionate	Fluticasone Propionate	81	35
Tramadol Hcl	Tramadol Hcl	80	22
Metoprolol Tartrate	Metoprolol Tartrate	77	25
Carvedilol	Carvedilol	75	19
Sertraline Hcl	Sertraline Hcl	74	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	17
Eliquis	Apixaban	72	13
Metformin Hcl Er	Metformin Hcl	69	18
Duloxetine Hcl	Duloxetine Hcl	66	13
Fluoxetine Hcl	Fluoxetine Hcl	63	17
Venlafaxine Hcl Er	Venlafaxine Hcl	63	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	61	14
Ozempic	Semaglutide	59	11
Albuterol Sulfate Hfa	Albuterol Sulfate	57	24
Clopidogrel	Clopidogrel Bisulfate	57	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	13
Spironolactone	Spironolactone	57	17
Metformin Hcl	Metformin Hcl	54	17
Mounjaro	Tirzepatide	51	suppressed
Bupropion Xl	Bupropion Hcl	50	13
Prednisone	Prednisone	49	33
Mirtazapine	Mirtazapine	48	14
Pravastatin Sodium	Pravastatin Sodium	47	19
Synthroid	Levothyroxine Sodium	45	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	suppressed
Diazepam	Diazepam	43	suppressed
Potassium Chloride	Potassium Chloride	42	14
Celecoxib	Celecoxib	40	suppressed
Farxiga	Dapagliflozin Propanediol	40	suppressed
Nystatin	Nystatin	40	11
Tizanidine Hcl	Tizanidine Hcl	40	11
Trazodone Hcl	Trazodone Hcl	40	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	suppressed
Glimepiride	Glimepiride	38	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	12
Zolpidem Tartrate	Zolpidem Tartrate	38	12
Atenolol	Atenolol	36	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Estradiol	Estradiol	35	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Jardiance	Empagliflozin	32	12
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Famotidine	Famotidine	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Fluconazole	Fluconazole	29	23
Myrbetriq	Mirabegron	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Hydrocortisone	Hydrocortisone	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	21
Valsartan	Valsartan	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Topiramate	Topiramate	25	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	13
Finasteride	Finasteride	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	19	suppressed
Cephalexin	Cephalexin	18	15
Lansoprazole	Lansoprazole	18	suppressed
Ondansetron Odt	Ondansetron	18	12
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Azithromycin	Azithromycin	17	16
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Ramipril	Ramipril	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Invokamet	Canagliflozin/Metformin Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error